Select octogenarians with stage IIIa non–small cell lung cancer can benefit from trimodality therapy

OBJECTIVES: Currently, more than 36% of patients diagnosed with lung cancer are 75 years of age or older. Management of stage IIIA cancer is variable, especially for octogenarians who might not be offered surgery because of questionable benefit. In this study we investigated the outcomes of definiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Andrew, Feczko, Andrew, Murthy, Sudish C., Raja, Siva, Bribriesco, Alejandro, Schraufnagel, Dean, Ahmad, Usman, Raymond, Daniel P., Sudarshan, Monisha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Thoracic: Lung Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390188/
https://www.ncbi.nlm.nih.gov/pubmed/36004217
http://dx.doi.org/10.1016/j.xjon.2022.01.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390188/
https://www.ncbi.nlm.nih.gov/pubmed/36004217
http://dx.doi.org/10.1016/j.xjon.2022.01.022

Ejemplares similares